ProfileGDS4718 / 219769_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 57% 52% 58% 57% 56% 55% 56% 57% 56% 58% 50% 59% 59% 53% 60% 52% 56% 55% 54% 60% 57% 59% 56% 58% 56% 56% 55% 53% 56% 56% 54% 61% 56% 57% 56% 53% 58% 56% 52% 61% 57% 51% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.867156
GSM549102patient 115, normal, homogenized [OPG study]5.9768857
GSM549104patient 119, normal, homogenized [OPG study]5.629252
GSM549108patient 138, normal, homogenized [OPG study]6.0478558
GSM549119patient 077, normal, homogenized [OPG study]5.9527157
GSM549133patient 032, cancer, homogenized [OPG study]5.8331856
GSM549139patient 042, cancer, homogenized [OPG study]5.8179655
GSM549099patient 107, normal, homogenized [OPG study]5.8625856
GSM549109patient 139, normal, homogenized [OPG study]5.9498657
GSM549110patient 046, normal, homogenized [OPG study]5.8550456
GSM549114patient 063, normal, homogenized [OPG study]5.9252558
GSM549122patient 082, normal, homogenized [OPG study]5.5214150
GSM549134patient 033, cancer, homogenized [OPG study]6.0431859
GSM549136patient 036, cancer, homogenized [OPG study]6.0488459
GSM549140patient 044, cancer, homogenized [OPG study]5.6696653
GSM549111patient 047, normal, homogenized [OPG study]6.1011560
GSM549113patient 057, normal, homogenized [OPG study]5.573552
GSM549132patient 031, cancer, homogenized [OPG study]5.855356
GSM549137patient 038, cancer, homogenized [OPG study]5.782555
GSM549142patient 047, cancer, homogenized [OPG study]5.895654
GSM549100patient 110, normal, homogenized [OPG study]6.0976960
GSM549107patient 135, normal, homogenized [OPG study]5.8816357
GSM549115patient 068, normal, homogenized [OPG study]6.0096759
GSM549116patient 072, normal, homogenized [OPG study]5.8639256
GSM549120patient 078, normal, homogenized [OPG study]6.0203858
GSM549131patient 030, cancer, homogenized [OPG study]5.8381356
GSM549118patient 074, normal, homogenized [OPG study]5.8656756
GSM549129patient 027, cancer, homogenized [OPG study]5.811455
GSM549123patient 088, normal, homogenized [OPG study]5.6857553
GSM549124patient 006, cancer, homogenized [OPG study]5.868356
GSM549126patient 015, cancer, homogenized [OPG study]5.8745756
GSM549128patient 025, cancer, homogenized [OPG study]5.720254
GSM549103patient 117, normal, homogenized [OPG study]6.1708661
GSM549117patient 073, normal, homogenized [OPG study]5.7869356
GSM549138patient 041, cancer, homogenized [OPG study]5.9300957
GSM549141patient 045, cancer, homogenized [OPG study]5.8769456
GSM549130patient 028, cancer, homogenized [OPG study]5.7025653
GSM549101patient 111, normal, homogenized [OPG study]6.0104658
GSM549105patient 128, normal, homogenized [OPG study]5.8651956
GSM549106patient 134, normal, homogenized [OPG study]5.5622752
GSM549112patient 048, normal, homogenized [OPG study]6.1846361
GSM549125patient 011, cancer, homogenized [OPG study]5.9168357
GSM549127patient 024, cancer, homogenized [OPG study]5.5831451
GSM549135patient 035, cancer, homogenized [OPG study]6.2703762